New platform coming soon — AI-Based Analysis with Human-Generated Insights

Market News & Insights

American Analyst Ratings Updates: November 17th, 2026

American Analyst Ratings Updates: November 17th, 2026

Analyst Ratings (USA)

American Airlines Group (AAL) — UBS Group raised its price target from $16.00 to $17.00, maintaining a Buy rating.

Advance Auto Parts (AAP) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $47.00.

Ascentage Pharma Group International (AAPG) — BTIG Research maintained its Buy rating with a price target of $48.00.

Ameris Bancorp (ABCB) — DA Davidson maintained its Buy rating with a price target of $96.00.

Arch Capital Group (ACGL) — Morgan Stanley raised its price target from $103.00 to $113.00, maintaining an Equal Weight rating.

Albertsons Companies (ACI) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $14.00.

AECOM (ACM) — Robert W. Baird raised its price target from $65.00 to $86.00, maintaining a Neutral rating.

Aclaris Therapeutics (ACRS) — Canaccord Genuity Group lowered its price target from $13.00 to $12.00, maintaining a Buy rating.

Aclaris Therapeutics (ACRS) — Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $8.00 to $3.00.

Acrivon Therapeutics (ACRV) — Citizens Jmp maintained its Market Outperform rating.

Autodesk (ADSK) — KeyCorp maintained its Overweight rating.

Atlas Energy Solutions (AESI) — Glj Research maintained its Buy rating with a price target of $13.00.

Affirm (AFRM) — Truist Financial lowered its price target from $88.00 to $86.00, maintaining a Buy rating.

Exp World (AGNT) — StoneX lowered its price target from $6.00 to $5.00, maintaining a Buy rating.

American International Group (AIG) — Morgan Stanley raised its price target from $80.00 to $85.00, maintaining an Equal Weight rating.

American Integrity Insurance Group (AII) — Keefe, Bruyette & Woods raised its price target from $31.00 to $34.00, maintaining an Outperform rating.

AirJoule Technologies (AIRJ) — B. Riley Financial lowered its price target from $8.00 to $6.00, maintaining a Buy rating.

AirJoule Technologies (AIRJ) — D. Boral Capital maintained its Buy rating with a price target of $8.00.

AirJoule Technologies (AIRJ) — UBS Group downgraded the stock to Neutral.

Arthur J. Gallagher & Co. (AJG) — Argus raised its price target from $300.00 to $317.00, maintaining a Buy rating.

Aktis Oncology (AKTS) — Raymond James Financial maintained its Strong-Buy rating.

Alaska Air Group (ALK) — UBS Group raised its price target from $48.00 to $54.00, maintaining a Buy rating.

Allstate (ALL) — Morgan Stanley raised its price target from $260.00 to $275.00, maintaining an Equal Weight rating.

Allot (ALLT) — Freedom Broker lowered its price target from $13.90 to $12.70, maintaining a Buy rating.

Almonty Industries (ALM) — B. Riley Financial lowered its price target from $20.00 to $18.00, maintaining a Buy rating.

Alnylam Pharmaceuticals (ALNY) — Cantor Fitzgerald lowered its price target from $290.00 to $205.00, maintaining a Neutral rating.

Alnylam Pharmaceuticals (ALNY) — HC Wainwright lowered its price target from $455.00 to $250.00, maintaining a Buy rating.

American Homes 4 Rent (AMH) — Citizens Jmp maintained its Market Outperform rating with a price target of $37.00.

American Tower (AMT) — Deutsche Bank initiated coverage with a Buy rating and a price target of $222.00.

Amazon.com (AMZN) — UBS Group initiated coverage with a Buy rating and a price target of $340.00.

Apollo Global Management (APO) — Mizuho initiated coverage with an Outperform rating and a price target of $145.00.

Ardent Health (ARDT) — Truist Financial raised its price target from $13.00 to $22.00, maintaining a Buy rating.

Ares Management (ARES) — Mizuho initiated coverage with an Outperform rating and a price target of $159.00.

Aramark (ARMK) — UBS Group raised its price target from $65.00 to $68.00, maintaining a Buy rating.

Aramark (ARMK) — Morgan Stanley lowered its price target from $63.00 to $61.00, maintaining an Equal Weight rating.

Aramark (ARMK) — Robert W. Baird lowered its price target from $69.00 to $65.00, maintaining an Outperform rating.

Aramark (ARMK) — JPMorgan Chase & Co. lowered its price target from $70.00 to $69.00, maintaining an Overweight rating.

Arrowhead Pharmaceuticals (ARWR) — Citigroup lowered its price target from $108.00 to $105.00, maintaining a Buy rating.

Amer Sports (AS) — Jefferies Financial Group maintained its Buy rating.

Ascendis Pharma A/S (ASND) — Jefferies Financial Group maintained its Buy rating.

Actinium Pharmaceuticals (ATNM) — HC Wainwright maintained its Buy rating with a price target of $4.00.

AXT (AXTI) — B. Riley Financial lowered its price target from $56.00 to $43.00, maintaining a Neutral rating.

Aytu BioPharma (AYTU) — Maxim Group downgraded the stock from Buy to Hold.

Aytu BioPharma (AYTU) — Lake Street Capital downgraded the stock from Buy to Hold, with a price target of $2.70.

AutoZone (AZO) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $3,450.00.

Bally’s (BALY) — Stifel Nicolaus lowered its price target from $13.00 to $12.00, maintaining a Hold rating.

BigBear.ai (BBAI) — HC Wainwright initiated coverage with a Buy rating and a price target of $4.00.

Best Buy (BBY) — UBS Group raised its price target from $90.00 to $103.00, maintaining a Neutral rating.

Best Buy (BBY) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $100.00.

Portman Ridge Finance (BCIC) — Oppenheimer lowered its price target from $11.00 to $9.00, maintaining a Market Perform rating.

Franklin Resources (BEN) — Mizuho initiated coverage with a Neutral rating and a price target of $38.00.

Brookfield Renewable Partners (BEP) — Morgan Stanley raised its price target from $37.00 to $39.00, maintaining an Overweight rating.

Brookfield Renewable (BEPC) — Morgan Stanley raised its price target from $37.00 to $39.00, maintaining an Underweight rating.

Baidu (BIDU) — StoneX lowered its price target from $150.00 to $125.00, maintaining a Buy rating.

Baidu (BIDU) — Freedom Broker lowered its price target from $160.00 to $150.00, maintaining a Buy rating.

BILL (BILL) — Truist Financial raised its price target from $50.00 to $58.00, maintaining a Hold rating.

BJ’s Wholesale Club (BJ) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $105.00.

BKV (BKV) — Citigroup raised its price target from $31.00 to $32.00, maintaining a Buy rating.

Bausch + Lomb (BLCO) — Barclays raised its price target from $24.00 to $27.00, maintaining an Overweight rating.

Ballard Power Systems (BLDP) — Raymond James Financial set a price target of $2.20, with a Market Perform rating.

Ballard Power Systems (BLDP) — KeyCorp maintained its Sector Weight rating.

BlackRock (BLK) — Mizuho initiated coverage with an Outperform rating and a price target of $1,450.00.

Bumble (BMBL) — Citigroup raised its price target from $3.20 to $6.05, maintaining a Neutral rating.

Baldwin Insurance Group (BWIN) — Raymond James Financial reiterated its coverage with a price target of $32.16.

Blackstone (BX) — Mizuho initiated coverage with an Outperform rating and a price target of $139.00.

Blackstone (BX) — Deutsche Bank maintained its Buy rating.

Blackstone (BX) — Royal Bank Of Canada raised its price target from $24.00 to $26.00, maintaining an Outperform rating.

Cardinal Health (CAH) — Wells Fargo & Company raised its price target from $277.00 to $321.00, maintaining an Overweight rating.

Cars.com (CARS) — BTIG Research maintained its Buy rating with a price target of $16.00.

Casey’s General Stores (CASY) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $800.00.

Coastal Financial (CCB) — Raymond James Financial maintained its Outperform rating.

Crown Castle (CCI) — Deutsche Bank initiated coverage with a Hold rating and a price target of $96.00.

CG Oncology (CGON) — JPMorgan Chase & Co. raised its price target from $96.00 to $113.00, maintaining an Overweight rating.

CG Oncology (CGON) — Royal Bank Of Canada downgraded the stock from Outperform to Sector Perform and raised its price target from $80.00 to $97.00.

CG Oncology (CGON) — HC Wainwright raised its price target from $100.00 to $115.00, maintaining a Buy rating.

CG Oncology (CGON) — Truist Financial raised its price target from $85.00 to $100.00, maintaining a Buy rating.

CG Oncology (CGON) — Wedbush raised its price target from $84.00 to $91.00, maintaining an Outperform rating.

Church & Dwight (CHD) — Wells Fargo & Company raised its price target from $115.00 to $125.00, maintaining an Overweight rating.

Chewy (CHWY) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $22.00.

Citizens (CIZN) — Citizens Jmp set a price target of $16.00.

Centene (CNC) — Sanford C. Bernstein maintained its Outperform rating.

Connect Biopharma (CNTB) — Canaccord Genuity Group maintained its Buy rating.

Cencora (COR) — Wells Fargo & Company raised its price target from $395.00 to $400.00, maintaining an Overweight rating.

Costco Wholesale (COST) — Mizuho raised its price target from $1,100.00 to $1,150.00, maintaining an Outperform rating.

Costco Wholesale (COST) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $1,220.00.

Corebridge Financial (CRBG) — Mizuho raised its price target from $41.00 to $42.00, maintaining an Outperform rating.

Cisco Systems (CSCO) — HSBC upgraded the stock from Hold to Buy and raised its price target from $120.00 to $133.00.

Cisco Systems (CSCO) — DZ Bank upgraded the stock from Hold to Buy, with a price target of $125.00.

Carvana (CVNA) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $85.00.

Clearway Energy (CWEN) — Morgan Stanley raised its price target from $52.00 to $53.00, maintaining an Overweight rating.

Community Health Systems (CYH) — Royal Bank Of Canada lowered its price target from $4.00 to $3.00, maintaining an Outperform rating.

Cypherpunk Technologies (CYPH) — Cantor Fitzgerald raised its price target from $4.90 to $5.00, maintaining an Overweight rating.

Delta Air Lines (DAL) — UBS Group raised its price target from $102.00 to $113.00, maintaining a Buy rating.

Diageo (DEO) — TD Cowen maintained its Buy rating.

Definium Therapeutics (DFTX) — JPMorgan Chase & Co. raised its price target from $84.00 to $85.00, maintaining an Overweight rating.

Dollar General (DG) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $145.00.

Dollar Tree (DLTR) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $160.00.

Alpha Tau Medical (DRTS) — HC Wainwright maintained its Buy rating with a price target of $16.00.

Alpha Tau Medical (DRTS) — UBS Group maintained its Buy rating.

Duos Technologies Group (DUOT) — Cantor Fitzgerald lowered its price target from $24.00 to $15.00, maintaining an Overweight rating.

Equifax (EFX) — BMO Capital Markets raised its price target from $175.00 to $186.00, maintaining a Market Perform rating.

Equifax (EFX) — Lake Street Capital downgraded the stock to Hold.

Everest Group (EG) — Morgan Stanley raised its price target from $395.00 to $425.00, maintaining an Equal Weight rating.

EMCOR Group (EME) — Morgan Stanley initiated coverage with an Overweight rating and a price target of $799.00.

Emerson Electric (EMR) — Morgan Stanley raised its price target from $140.00 to $175.00, maintaining an Underweight rating.

Equitable (EQH) — Mizuho lowered its price target from $67.00 to $65.00, maintaining an Outperform rating.

Erasca (ERAS) — Leerink Partners initiated coverage with an Outperform rating and a price target of $35.00.

Elbit Systems (ESLT) — Jefferies Financial Group maintained its Hold rating.

Elastic (ESTC) — TD Cowen lowered its price target from $95.00 to $85.00, maintaining a Hold rating.

enCore Energy (EU) — B. Riley Financial lowered its price target from $2.50 to $1.75, maintaining a Buy rating.

Expeditors International of Washington (EXPD) — Barclays raised its price target from $175.00 to $200.00, maintaining an Underweight rating.

Diamondback Energy (FANG) — Truist Financial raised its price target from $232.00 to $242.00, maintaining a Buy rating.

Diamondback Energy (FANG) — Mizuho set a price target of $248.00.

Diamondback Energy (FANG) — Sanford C. Bernstein maintained its Market Perform rating.

FTAI Infrastructure (FIP) — JonesTrading set a price target of $8.75.

Five Below (FIVE) — Mizuho raised its price target from $295.00 to $300.00, maintaining an Outperform rating.

Five Below (FIVE) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $235.00.

Comfort Systems USA (FIX) — Morgan Stanley initiated coverage with an Overweight rating and a price target of $1,410.00.

Flex (FLEX) — Raymond James Financial set a price target of $150.00, with an Outperform rating.

Forgent Power Solutions (FPS) — Wells Fargo & Company lowered its price target from $44.00 to $25.00, maintaining an Equal Weight rating.

Forum Markets (FRMM) — StoneX lowered its price target from $12.00 to $10.00, maintaining a Speculative Buy rating.

FitLife Brands (FTLF) — Lake Street Capital lowered its price target from $18.00 to $12.00, maintaining a Buy rating.

GCT Semiconductor (GCTS) — HC Wainwright initiated coverage with a Buy rating and a price target of $3.00.

GH Research (GHRS) — HC Wainwright lowered its price target from $7.00 to $3.00, maintaining a Buy rating.

Alphabet (GOOG) — UBS Group changed its rating from Neutral to Buy and lowered its price target from $380.00 to $320.00.

Genuine Parts (GPC) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $130.00.

Grindr (GRND) — Citizens Jmp raised its price target from $21.00 to $33.00, maintaining a Market Outperform rating.

Grindr (GRND) — Citigroup maintained its Market Outperform rating.

GXO Logistics (GXO) — Citigroup raised its price target from $66.00 to $71.00, maintaining a Buy rating.

GXO Logistics (GXO) — UBS Group raised its price target from $69.00 to $72.00, maintaining a Buy rating.

GXO Logistics (GXO) — Wells Fargo & Company raised its price target from $65.00 to $75.00, maintaining an Overweight rating.

GXO Logistics (GXO) — Morgan Stanley raised its price target from $78.00 to $85.00, maintaining an Overweight rating.

GXO Logistics (GXO) — Stifel Nicolaus raised its price target from $72.00 to $79.00, maintaining a Buy rating.

HA Sustainable Infrastructure Capital (HASI) — Morgan Stanley raised its price target from $60.00 to $61.00, maintaining an Overweight rating.

Home Depot (HD) — TD Cowen maintained its Outperform rating.

Home Depot (HD) — Evercore maintained its Outperform rating.

Home Depot (HD) — TD Cowen set a price target of $410.00.

Hess Midstream Partners (HESM) — Morgan Stanley raised its price target from $30.00 to $32.00, maintaining an Underweight rating.

The Hartford Insurance Group (HIG) — Morgan Stanley raised its price target from $135.00 to $145.00, maintaining an Equal Weight rating.

Hallador Energy (HNRG) — B. Riley Financial lowered its price target from $29.00 to $27.00, maintaining a Buy rating.

Henry Schein (HSIC) — Morgan Stanley raised its price target from $64.00 to $68.00, maintaining an Underweight rating.

H World Group (HTHT) — StoneX raised its price target from $60.00 to $64.00, maintaining a Buy rating.

Humana (HUM) — Sanford C. Bernstein maintained its Outperform rating.

TuHURA Biosciences (HURA) — HC Wainwright maintained its Buy rating.

IDACORP (IDA) — Jefferies Financial Group downgraded the stock from Buy to Hold and raised its price target from $155.00 to $163.00.

IDEAYA Biosciences (IDYA) — Royal Bank Of Canada maintained its Outperform rating with a price target of $45.00.

Immatics (IMTX) — Jefferies Financial Group maintained its Buy rating.

Incyte (INCY) — Jefferies Financial Group set a price target of $115.00, with a Hold rating.

Infleqtion (INFQ) — Wedbush maintained its Outperform rating with a price target of $20.00.

Infleqtion (INFQ) — Canaccord Genuity Group lowered its price target from $22.00 to $17.00, maintaining a Buy rating.

Inter & Co. Inc. (INTR) — JPMorgan Chase & Co. lowered its price target from $11.00 to $7.50, maintaining an Overweight rating.

Intuit (INTU) — Wells Fargo & Company raised its price target from $300.00 to $330.00, maintaining an Equal Weight rating.

iQIYI (IQ) — New Street Research downgraded the stock from Buy to Neutral.

iQIYI (IQ) — StoneX maintained its Hold rating.

Ispire Technology (ISPR) — BTIG Research set a price target of $2.90, with a Buy rating.

Intuitive Surgical (ISRG) — BMO Capital Markets maintained its Outperform rating.

Invesco (IVZ) — Mizuho initiated coverage with an Outperform rating and a price target of $37.00.

JD.com (JD) — Jefferies Financial Group lowered its price target from $50.00 to $43.00, maintaining a Buy rating.

Jasper Therapeutics (JSPR) — Piper Sandler maintained its Overweight rating.

Kimco Realty (KIM) — BNP Paribas Exane initiated coverage with an Outperform rating and a price target of $29.00.

KKR & Co. Inc. (KKR) — Mizuho initiated coverage with an Outperform rating and a price target of $116.00.

Kimberly-Clark (KMB) — JPMorgan Chase & Co. initiated coverage with a Neutral rating and a price target of $113.00.

CarMax (KMX) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $55.00.

Kiniksa Pharmaceuticals International (KNSA) — TD Cowen raised its price target from $100.00 to $115.00, maintaining a Buy rating.

Coca-Cola (KO) — TD Cowen raised its price target from $104.00 to $112.00, maintaining a Buy rating.

Coca Cola FEMSA (KOF) — UBS Group raised its price target from $113.00 to $124.00, maintaining a Neutral rating.

Kroger (KR) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $80.00.

Kohl’s (KSS) — Telsey Advisory Group raised its price target from $18.00 to $25.00, maintaining a Market Perform rating.

Largo (LGO) — HC Wainwright maintained its Buy rating with a price target of $0.90.

Lumentum (LITE) — B. Riley Financial lowered its price target from $770.00 to $659.00, maintaining a Neutral rating.

Eli Lilly and Company (LLY) — Royal Bank Of Canada maintained its Outperform rating with a price target of $1,600.00.

Lumexa Imaging (LMRI) — Barclays raised its price target from $13.00 to $17.00, maintaining an Overweight rating.

Lincoln National (LNC) — Mizuho raised its price target from $50.00 to $51.00, maintaining an Outperform rating.

Athira Pharma (LONA) — Citizens Jmp lowered its price target from $17.00 to $16.00, maintaining a Market Outperform rating.

Southwest Airlines (LUV) — UBS Group raised its price target from $54.00 to $59.00, maintaining a Buy rating.

Lightwave Logic (LWLG) — Freedom Broker maintained its Buy rating.

Mobileye Global (MBLY) — Citigroup lowered its price target from $11.00 to $10.00, maintaining a Buy rating.

Microbot Medical (MBOT) — Citigroup maintained its Market Outperform rating.

Microbot Medical (MBOT) — Citizens Jmp lowered its price target from $2.50 to $2.00, maintaining a Market Outperform rating.

Medtronic (MDT) — Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $85.00 to $120.00.

Medtronic (MDT) — TD Cowen set a price target of $110.00, with a Buy rating.

MiMedx Group (MDXG) — Cantor Fitzgerald maintained its Overweight rating with a price target of $8.00.

Meta Platforms (META) — UBS Group initiated coverage with a Buy rating and a price target of $815.00.

Mosaic (MOS) — UBS Group raised its price target from $19.00 to $22.00, maintaining a Neutral rating.

Maplight Therapeutics (MPLT) — Canaccord Genuity Group maintained its Buy rating with a price target of $21.00.

Moderna (MRNA) — JPMorgan Chase & Co. raised its price target from $77.00 to $102.00, maintaining an Underweight rating.

Moderna (MRNA) — Morgan Stanley raised its price target from $95.00 to $200.00, maintaining an Equal Weight rating.

MasTec (MTZ) — Morgan Stanley initiated coverage with an Equal Weight rating and a price target of $220.00.

Murphy USA (MUSA) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $545.00.

NCR Atleos (NATL) — DA Davidson maintained its Neutral rating with a price target of $50.00.

NewJersey Resources (NJR) — Jefferies Financial Group lowered its price target from $56.00 to $54.00, maintaining a Hold rating.

Neumora Therapeutics (NMRA) — Guggenheim maintained its Buy rating.

Nutanix (NTNX) — Rosenblatt Securities maintained its Buy rating with a price target of $75.00.

Netskope (NTSK) — Rosenblatt Securities raised its price target from $19.00 to $28.00, maintaining a Buy rating.

Nucor (NUE) — Morgan Stanley upgraded the stock from Equal Weight to Overweight and raised its price target from $300.00 to $310.00.

Nuvation Bio (NUVB) — HC Wainwright maintained its Buy rating with a price target of $21.00.

Nextpower (NXT) — JPMorgan Chase & Co. lowered its price target from $134.00 to $133.00, maintaining an Overweight rating.

Nextpower (NXT) — BMO Capital Markets lowered its price target from $114.00 to $108.00, maintaining an Outperform rating.

Nextpower (NXT) — Truist Financial set a price target of $145.00.

Nextpower (NXT) — Citigroup maintained its Buy rating.

Oculis (OCS) — HC Wainwright maintained its Buy rating with a price target of $39.00.

Ocular Therapeutix (OCUL) — HC Wainwright maintained its Buy rating with a price target of $28.00.

Okta (OKTA) — Cantor Fitzgerald maintained its Overweight rating with a price target of $250.00.

Omeros (OMER) — HC Wainwright maintained its Buy rating with a price target of $33.00.

OneWater Marine (ONEW) — Raymond James Financial maintained its Market Perform rating.

Oric Pharmaceuticals (ORIC) — Wedbush maintained its Outperform rating.

Oric Pharmaceuticals (ORIC) — Citigroup raised its price target from $16.00 to $17.00, maintaining a Buy rating.

Oric Pharmaceuticals (ORIC) — BTIG Research maintained its Buy rating with a price target of $26.00.

O’Reilly Automotive (ORLY) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $105.00.

Penske Automotive Group (PAG) — Citigroup raised its price target from $210.00 to $212.00, maintaining a Neutral rating.

Plains GP (PAGP) — Morgan Stanley lowered its price target from $28.00 to $27.00, maintaining an Equal Weight rating.

Palo Alto Networks (PANW) — Guggenheim maintained its Neutral rating.

Petroleo Brasileiro S.A. – Petrobras (PBR) — Citigroup lowered its price target from $21.50 to $18.50, maintaining a Neutral rating.

PagerDuty (PD) — Truist Financial raised its price target from $15.00 to $17.00, maintaining a Buy rating.

Penumbra (PEN) — Canaccord Genuity Group maintained its Hold rating with a price target of $374.00.

PepsiCo (PEP) — Sanford C. Bernstein downgraded the stock from Market Perform to Underperform and lowered its price target from $131.00 to $128.00.

Progyny (PGNY) — Truist Financial raised its price target from $36.00 to $42.00, maintaining a Buy rating.

Progressive (PGR) — Morgan Stanley raised its price target from $210.00 to $235.00, maintaining an Equal Weight rating.

Parker-Hannifin (PH) — Morgan Stanley lowered its price target from $16.00 to $9.00, maintaining an Outperform rating.

Pulse Biosciences (PLSE) — Needham & Company LLC maintained its Buy rating.

Philip Morris International (PM) — BTIG Research set a price target of $225.00, with a Buy rating.

The Pennant Group (PNTG) — Wells Fargo & Company raised its price target from $46.00 to $49.00, maintaining an Overweight rating.

Pool (POOL) — DA Davidson maintained its Neutral rating with a price target of $200.00.

People Incorporated Common Stock (PPLI) — Truist Financial set a price target of $59.00.

Perpetua Resources (PPTA) — HC Wainwright maintained its Buy rating with a price target of $43.50.

Praxis Precision Medicines (PRAX) — Wells Fargo & Company changed its rating from Positive to Overweight and raised its price target from $343.00 to $509.00.

PROG (PRG) — Loop Capital downgraded the stock from Buy to Hold, with a price target of $40.00.

Quanta Services (PWR) — Morgan Stanley initiated coverage with an Equal Weight rating and a price target of $636.00.

Rubrik (RBRK) — Oppenheimer raised its price target from $120.00 to $150.00, maintaining an Outperform rating.

Rubrik (RBRK) — Cantor Fitzgerald raised its price target from $120.00 to $125.00, maintaining an Overweight rating.

Red Cat (RCAT) — Piper Sandler lowered its price target from $6.00 to $3.00, maintaining a Neutral rating.

Red Cat (RCAT) — HC Wainwright lowered its price target from $20.00 to $10.00, maintaining a Buy rating.

Red Cat (RCAT) — Needham & Company LLC lowered its price target from $15.00 to $5.00, maintaining a Buy rating.

Rocket Pharmaceuticals (RCKT) — Chardan Capital maintained its Buy rating with a price target of $11.00.

Regeneron Pharmaceuticals (REGN) — Barclays raised its price target from $917.00 to $1,075.00, maintaining an Overweight rating.

Rivian Automotive (RIVN) — StoneX lowered its price target from $25.00 to $20.00, maintaining a Buy rating.

RenaissanceRe (RNR) — Morgan Stanley raised its price target from $335.00 to $365.00, maintaining an Equal Weight rating.

Rapid Micro Biosystems (RPID) — Roth Capital downgraded the stock from Buy to Neutral and lowered its price target from $3.00 to $0.75.

Rapid Micro Biosystems (RPID) — JPMorgan Chase & Co. set a price target of $0.75.

Range Resources (RRC) — Susquehanna raised its price target from $44.00 to $52.00, maintaining a Neutral rating.

Revolution Medicines (RVMD) — HC Wainwright maintained its Buy rating with a price target of $350.00.

Redwood Trust (RWT) — BTIG Research lowered its price target from $5.00 to $4.50, maintaining a Buy rating.

Rezolute (RZLT) — Wedbush raised its price target from $6.00 to $10.00, maintaining an Outperform rating.

Rezolve AI (RZLV) — HC Wainwright initiated coverage with a Buy rating and a price target of $6.00.

SBA Communications (SBAC) — Deutsche Bank initiated coverage with a Hold rating and a price target of $211.00.

Stellus Capital Investment (SCM) — Keefe, Bruyette & Woods lowered its price target from $8.00 to $7.50, maintaining a Market Perform rating.

Sprouts Farmers Market (SFM) — B. Riley Financial lowered its price target from $109.00 to $45.00, maintaining an Overweight rating.

Shoals Technologies Group (SHLS) — UBS Group downgraded the stock from Buy to Neutral and lowered its price target from $12.00 to $9.00.

Selective Insurance Group (SIGI) — Morgan Stanley raised its price target from $85.00 to $90.00, maintaining an Underweight rating.

Skydance (SKYD) — Freedom Broker lowered its price target from $10.00 to $8.50, maintaining a Hold rating.

Slide Insurance (SLDE) — Morgan Stanley raised its price target from $24.00 to $27.00, maintaining an Equal Weight rating.

Soluna (SLNH) — Rosenblatt Securities maintained its Buy rating with a price target of $2.00.

SharkNinja (SN) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $255.00.

Snowflake (SNOW) — BTIG Research maintained its Buy rating with a price target of $424.00.

TD SYNNEX (SNX) — Barclays lowered its price target from $287.00 to $282.00, maintaining an Equal Weight rating.

SoundHound AI (SOUN) — HC Wainwright initiated coverage with a Buy rating and a price target of $7.00.

SpaceX (SPCX) — Cantor Fitzgerald maintained its Overweight rating with a price target of $345.00.

Simon Property Group (SPG) — Citigroup raised its price target from $230.00 to $237.00, maintaining a Neutral rating.

Spire (SR) — BTIG Research maintained its Buy rating.

Stellantis (STLA) — Oddo Bhf downgraded the stock from Neutral to Underperform, with a price target of $3.30.

Steel Dynamics (STLD) — Morgan Stanley raised its price target from $260.00 to $270.00, maintaining an Equal Weight rating.

Stanley Black & Decker (SWK) — Mizuho downgraded the stock from Outperform to Neutral and raised its price target from $105.00 to $120.00.

Sysco (SYY) — Guggenheim maintained its Buy rating.

Teva Pharmaceutical Industries (TEVA) — Argus raised its price target from $42.00 to $50.00, maintaining a Buy rating.

Teva Pharmaceutical Industries (TEVA) — HC Wainwright maintained its Buy rating with a price target of $54.00.

Target (TGT) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $155.00.

TIM (TIMB) — Itau BBA Securities upgraded the stock from Market Perform to Outperform.

TIM (TIMB) — Bank of America downgraded the stock from Buy to Neutral, with a price target of $21.00.

T-Mobile US (TMUS) — Citigroup raised its price target from $165.00 to $185.00, maintaining a Neutral rating.

Turning Point Brands (TPB) — Compass Point set a price target of $101.00.

Turning Point Brands (TPB) — BTIG Research maintained its Buy rating.

TPG (TPG) — Mizuho initiated coverage with a Neutral rating and a price target of $52.00.

T. Rowe Price Group (TROW) — Mizuho initiated coverage with a Underperform rating and a price target of $94.00.

Tractor Supply (TSCO) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $35.00.

Tesla (TSLA) — Barclays maintained its Overweight rating.

Tyson Foods (TSN) — Sanford C. Bernstein raised its price target from $66.00 to $72.00, maintaining a Market Perform rating.

Tyson Foods (TSN) — BMO Capital Markets raised its price target from $65.00 to $75.00, maintaining an Outperform rating.

Tyson Foods (TSN) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral and raised its price target from $63.00 to $65.00.

Tyson Foods (TSN) — Piper Sandler raised its price target from $56.00 to $72.00, maintaining an Overweight rating.

United Airlines (UAL) — UBS Group raised its price target from $139.00 to $147.00, maintaining a Buy rating.

Frontier Group (ULCC) — UBS Group raised its price target from $7.00 to $8.00, maintaining a Neutral rating.

United Natural Foods (UNFI) — The Goldman Sachs Group upgraded the stock from Neutral to Buy and raised its price target from $49.00 to $60.00.

US Foods (USFD) — JPMorgan Chase & Co. raised its price target from $98.00 to $110.00, maintaining a Neutral rating.

VEON (VEON) — StoneX raised its price target from $85.00 to $92.00, maintaining a Buy rating.

Veritone (VERI) — Needham & Company LLC maintained its Buy rating.

Vistra (VST) — Sanford C. Bernstein raised its price target from $181.00 to $182.00, maintaining an Outperform rating.

Vistra (VST) — BMO Capital Markets raised its price target from $188.00 to $196.00, maintaining an Outperform rating.

Victoria’s Secret & Co. (VSXY) — BMO Capital Markets raised its price target from $80.00 to $100.00, maintaining a Market Perform rating.

Wayfair (W) — Guggenheim maintained its Buy rating.

Wayfair (W) — Stifel Nicolaus initiated coverage with a Hold rating and a price target of $120.00.

WBI (WBI) — Morgan Stanley lowered its price target from $43.00 to $41.00, maintaining an Overweight rating.

Workday (WDAY) — Piper Sandler set a price target of $190.00, with a Neutral rating.

Workday (WDAY) — UBS Group maintained its Neutral rating.

Western Midstream Partners (WES) — Morgan Stanley lowered its price target from $52.00 to $50.00, maintaining an Equal Weight rating.

Walmart (WMT) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $145.00.

W.R. Berkley (WRB) — Morgan Stanley raised its price target from $70.00 to $80.00, maintaining an Equal Weight rating.

Williams-Sonoma (WSM) — Barclays raised its price target from $190.00 to $240.00, maintaining an Equal Weight rating.

Williams-Sonoma (WSM) — Stifel Nicolaus initiated coverage with a Buy rating and a price target of $290.00.

Xenon Pharmaceuticals (XENE) — JPMorgan Chase & Co. lowered its price target from $82.00 to $80.00, maintaining an Overweight rating.

XPLR Infrastructure (XIFR) — Morgan Stanley lowered its price target from $11.00 to $9.00, maintaining an Underweight rating.

XPENG (XPEV) — Freedom Broker lowered its price target from $22.00 to $20.00, maintaining a Buy rating.

XPENG (XPEV) — Sanford C. Bernstein lowered its price target from $18.00 to $15.00, maintaining a Market Perform rating.

Zimmer Biomet (ZBH) — Wells Fargo & Company upgraded the stock from Equal Weight to Overweight and raised its price target from $113.00 to $123.00.

Zoom Communications (ZM) — Citigroup raised its price target from $126.00 to $131.00, maintaining a Buy rating.

Join the discussion

Your email address will not be published. Required fields are marked *